Penny stocks often look risky at first glance, especially when headlines swing between stronger manufacturing in parts of Europe and Asia and softer demand or slower activity elsewhere. The Financially Fit Penny Stocks screener focuses on companies trading below 5 that still show solid financial health. That can help you focus on lower risk profiles within this higher risk corner of the market. In this article you will see 3 of the stocks from this screener, with clear reasons why each one could deserve a closer look based on balance sheet quality, cash discipline and resilience in a mixed global backdrop.

Enovix (ENVX)

Overview: Enovix is a Fremont based battery company that designs and manufactures lithium ion cells for demanding uses such as wearables, smartphones, computing devices, electric vehicles and other equipment produced by major original equipment manufacturers.

Operations: Enovix generates about US$34.3 million in revenue from batteries and battery systems, with most reported sales coming from South Korea at roughly US$24.5 million.

Market Cap: US$898 million

Enovix catches attention in the penny stock space because it is trying to move leading edge battery technology from the lab into large scale production for smartphones, defense applications and smart eyewear. The company is still loss making and Q1 2026 showed a net loss of US$38.26 million, so execution on new plants in Malaysia and other locations, along with capital spending, is a key risk. At the same time, revenue growth forecasts are strong, analysts report meaningful upside in their price targets, and new leadership hires on the operations and sales side suggest a clear push toward commercial scale. Investors who care about balance sheet quality and future cash generation may want to evaluate potential outcomes if Enovix reaches its production and customer qualification milestones.

Enovix looks like a classic execution story, with ambitious capacity plans and a meaningful Q1 2026 loss that could either set up a powerful inflection or expose hidden pressure points. Get the full picture in the 1 key reward and 2 important warning signs

Clover Health Investments (CLOV)

Overview: Clover Health Investments provides Medicare Advantage plans for eligible individuals in the United States and supports physicians with Clover Assistant, a software platform that helps detect and manage chronic diseases using data driven insights. The company positions itself as a technology focused insurer aiming to improve care quality while managing costs.

Operations: Clover Health Investments generates about US$2.2b in revenue from its Insurance segment, all from the United States.

Market Cap: US$2.3b

Clover Health Investments stands out in the penny stock space because it blends a traditional Medicare Advantage insurer with a data heavy care platform that aims to reduce medical costs and improve outcomes. The company has moved from reporting losses to reporting a quarterly profit of US$27.33 million in Q1 2026. It still trades on a P/S of 1x that is below peers and the broader US Healthcare industry. Investors do need to weigh funding risk, ongoing reliance on Medicare Advantage policy support and recent insider sales, as well as a recent cyber incident in July. The bigger question is whether the market is fully pricing in the potential of Clover Assistant and the shift toward value based care.

Clover Health Investments has moved from losses to a Q1 2026 profit while still trading on a P/S of 1x. See how that mix of pricing, profitability and policy risk stacks up in the 3 key rewards and 1 important warning sign

Hyliion Holdings (HYLN)

Overview: Hyliion Holdings develops the KARNO Power Module, a fuel flexible generator that can supply on site electricity for uses such as data centers, industrial facilities and defense applications using fuels ranging from natural gas and propane to landfill gas and hydrogen.

Operations: Hyliion Holdings currently generates about US$5.8 million in revenue from Auto Parts & Accessories, all from the United States.

Market Cap: US$672.3 million

Hyliion Holdings sits at an interesting crossroads for investors looking at the Financially Fit Penny Stocks screener. The company is still early, with commercialization of KARNO targeted from 2026 and recent quarterly revenue of US$2.83 million alongside a net loss of US$11.74 million, so cash burn and a short runway remain front of mind. At the same time, a US$41.7 million U.S. Office of Naval Research contract, selection for DARPA backed sea trials and forecasts for very strong revenue growth indicate that large customers are willing to test the technology at scale. If you want to understand how that mix of long dated contracts, high funding risk and limited analyst coverage really stacks up, the full Hyliion story goes much further than these headlines.

Hyliion Holdings has early revenue, a US$41.7 million naval contract and long dated KARNO ambitions that the market may not fully be pricing. Get the full context in the 1 key reward and 3 important warning signs (2 are major!)

The three penny stocks in this article are only a small sample of what surfaced, with the full screener highlighting 335 more companies that pair low share prices with balance sheets and cash profiles that could support equally compelling narratives. If you want to identify and analyze the highest conviction setups for your own approach, unlock the full potential of this idea with the Financially Fit Penny Stocks screener

Take Control of Your Investment Journey

If Hyliion Holdings or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Before Others Do

New breakouts, shifting momentum and stocks flying under the radar for now can get picked over fast. Review these fresh ideas before the crowd catches on.

• Spot resilient growers with clean balance sheets by scanning a curated list of solid balance sheet and fundamentals (46 results) that keeps financially stretched companies off your shortlist.
• Review a focused group of 36 power grid technology and infrastructure stocks that are tied to long term infrastructure themes in the power and energy space.
• Explore structural metal demand with a hand picked pool of 8 top copper producer stocks that are connected to grids, renewables and large scale construction.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.